Загрузка...

Lapatinib: the evidence for its therapeutic value in metastatic breast cancer

INTRODUCTION: Breast cancer is the most common cancer affecting women. Many patients ultimately progress to metastatic disease and optimal management of this disease remains a significant therapeutic challenge. Lapatinib, a dual tyrosine kinase inhibitor, is in clinical development for treatment of...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Thomson, Andrew
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2005
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321658/
https://ncbi.nlm.nih.gov/pubmed/22500146
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!